Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: Zeev Hed who wrote (24662)	1/25/2002 2:23:33 PM
From: Sully-	Read Replies (1) \| Respond to of 99280

14:21 ET Imclone bounces after defended on CNBC (IMCL) 15.28 -4.30 (-22%): -- Update -- Two analysts interviewed on CNBC think that investors should stick with IMCL. Merrill Lynch analyst thinks issues are overblown, noting that IMCL is part of FDA fast-track program and is, therefore, encouraged to submit data early. IMCL had just broken to a new intraday low ahead of the comments. 14:07 ET Semtech Corp affirms Q4 consensus estimates (SMTC) 34.34 +0.84 (+2.5%): Announces that it expects Q4 EPS of $0.11 on sales of about $46.4 mln, in-line with current ests. The co plans to announce Q4 results on Feb 26 after the close of mkt.